董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Alan W. Milinazzo | 男 | Director | 56 | 19.21万 | 未持股 | 2016-03-10 |
| William W. Burke | 男 | Director | 56 | 25.21万 | 未持股 | 2016-03-10 |
| Christophe Lavigne | 男 | President, Chief Executive Officer and Chairman of the Board of Directors | 48 | 310.93万 | 未持股 | 2016-03-10 |
| Joseph Aragona | 男 | Director | 59 | 34.67万 | 未持股 | 2016-03-10 |
| Kevin M. Lalande | 男 | Director | 43 | 37.42万 | 未持股 | 2016-03-10 |
| Stefan Widensohler | 男 | Director | 56 | 37.04万 | 未持股 | 2016-03-10 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Christophe Lavigne | 男 | President, Chief Executive Officer and Chairman of the Board of Directors | 48 | 310.93万 | 未持股 | 2016-03-10 |
| Robert McNamara | 男 | Executive Vice President, Chief Financial Officer | 59 | 126.11万 | 未持股 | 2016-03-10 |
| Scott Way | 男 | Executive Vice President, General Counsel, Compliance Officer and Secretary | 44 | 未披露 | 未持股 | 2016-03-10 |
| Andre Potgieter | 男 | Executive Vice President, U.S. Sales, LDR Spine | 48 | 138.90万 | 未持股 | 2016-03-10 |
| James Burrows | 男 | Executive Vice President, Chief Operating Officer, LDR Spine | 46 | 106.09万 | 未持股 | 2016-03-10 |
| G. Joseph Ross | 男 | Executive Vice President, Global Marketing, LDR Spine | 48 | 106.09万 | 未持股 | 2016-03-10 |
| Patrick Richard | 男 | Executive Vice President of European Sales, Medical | 52 | 74.17万 | 未持股 | 2016-03-10 |
董事简历
中英对照 | 中文 | 英文- Alan W. Milinazzo
-
Alan W. Milinazzo目前是Heidrick & Struggles咨询公司的合伙人。从2013年到2016年，他担任InspireMD, Inc.(一家上市的介入设备公司，专注于开发新型栓塞保护产品)的总裁兼首席执行官。从2005年到2012年，他担任Orthofix International, N.V.(上市的全球骨科公司)的首席执行官和董事。2002年至2005年，他担任Medtronic Inc.的血管业务副总裁、冠状动脉和外围业务副总裁兼总经理。Milinazzo先生还曾担任Boston Scientific Corporation的执行职务。除了担任肌肉骨骼移植基金会的董事会成员外，他还担任Flexion Therapeutics Inc.的董事会成员。他曾担任inspirremd, Inc.的董事会成员;Orthofix International, N.V.;Medpace;和HET系统。Milinazzo先生以优异成绩毕业于波士顿学院。
Alan W. Milinazzo is currently a Partner of the consulting firm of Heidrick & Struggles. From 2013 to 2016 he served as President and Chief Executive Officer of InspireMD, Inc., a publicly-traded interventional device company focused on developing novel embolic protection products. From 2005 to 2012 he served as Chief Executive Officer and Director of Orthofix International, N.V., a publicly-traded global orthopedic company. From 2002 to 2005 he served as Vice President of the vascular business as well as Vice President and G.M. of the coronary and peripheral businesses at Medtronic Inc. Mr. Milinazzo also served in executive positions at Boston Scientific Corporation. In addition to being a board member on the board of the Musculoskeletal Transplant Foundation, he serves on the board of Flexion Therapeutics Inc. He formerly served on the boards of InspireMD, Inc.; Orthofix International, N.V.; Medpace; and HET Systems. Mr. Milinazzo graduated cum laude from Boston College. - Alan W. Milinazzo目前是Heidrick & Struggles咨询公司的合伙人。从2013年到2016年，他担任InspireMD, Inc.(一家上市的介入设备公司，专注于开发新型栓塞保护产品)的总裁兼首席执行官。从2005年到2012年，他担任Orthofix International, N.V.(上市的全球骨科公司)的首席执行官和董事。2002年至2005年，他担任Medtronic Inc.的血管业务副总裁、冠状动脉和外围业务副总裁兼总经理。Milinazzo先生还曾担任Boston Scientific Corporation的执行职务。除了担任肌肉骨骼移植基金会的董事会成员外，他还担任Flexion Therapeutics Inc.的董事会成员。他曾担任inspirremd, Inc.的董事会成员;Orthofix International, N.V.;Medpace;和HET系统。Milinazzo先生以优异成绩毕业于波士顿学院。
- Alan W. Milinazzo is currently a Partner of the consulting firm of Heidrick & Struggles. From 2013 to 2016 he served as President and Chief Executive Officer of InspireMD, Inc., a publicly-traded interventional device company focused on developing novel embolic protection products. From 2005 to 2012 he served as Chief Executive Officer and Director of Orthofix International, N.V., a publicly-traded global orthopedic company. From 2002 to 2005 he served as Vice President of the vascular business as well as Vice President and G.M. of the coronary and peripheral businesses at Medtronic Inc. Mr. Milinazzo also served in executive positions at Boston Scientific Corporation. In addition to being a board member on the board of the Musculoskeletal Transplant Foundation, he serves on the board of Flexion Therapeutics Inc. He formerly served on the boards of InspireMD, Inc.; Orthofix International, N.V.; Medpace; and HET Systems. Mr. Milinazzo graduated cum laude from Boston College.
- William W. Burke
-
William W. Burke，自2022年6月起担任Ceribell，Inc.董事会成员。从2015年11月到2024年6月担任Austin Highlands Advisors, LLC（企业咨询服务提供商）的总裁。2009年11月至2013年8月被Abbott Laboratories收购，他担任IDEV Technologies, Inc.（外围血管设备公司）的执行副总裁兼首席财务官。从2004年8月到2007年12月，他担任ReAble Therapeutics, Inc.的执行副总裁兼首席财务官，ReAble Therapeutics是一家多元化的骨科设备公司，于2006年出售给Blackstone Group进行私人交易，随后于2007年11月与DJO Incorporated合并。他一直在ReAble Therapeutics工作到2008年6月。从2001年到2004年，他担任Cholestech Corporation（医疗诊断产品公司）的首席财务官。他曾担任许多上市和私人公司的董事会成员，包括担任董事会主席和首席独立董事。他目前担任Nalu Medical（为慢性神经性疼痛患者提供微创解决方案的私人制造商）、Adtalem Global Education（医疗保健教育公司）和Tactile Systems Technology（为慢性疾病患者提供治疗的医疗技术公司）的董事会成员。他曾担任EQ Health Acquisition Corp.、Invuity, Inc.（2018年被Stryker Corporation收购）、LDR Holding Corporation（2016年被Zimmer Biomet收购）和Medical Action Industries Inc.（2014年被Owens & Minor收购）的董事会成员。他持有The University of Texas at Austin的金融学士学位和The Wharton School of The University of Pennsylvania的工商管理硕士学位。
William W. Burke,has been a director of Adtalem since January 2017. He served as Adtalem Global Education Inc. Lead Independent Director from July 2019 through November 2022. From November 2015 to June 2024, Mr. Burke served as President of Austin Highlands Advisors, LLC, a provider of corporate advisory services. He served as Executive Vice President & Chief Financial Officer of IDEV Technologies, a peripheral vascular devices company, from November 2009 until the company was acquired by Abbott Laboratories in August 2013. From August 2004 to December 2007, he served as Executive Vice President & Chief Financial Officer of ReAble Therapeutics, a diversified orthopedic device company which was sold to The Blackstone Group in a going private transaction in 2006 and subsequently merged with DJO Incorporated in November 2007. Mr. Burke remained with ReAble Therapeutics until June 2008. From 2001 to 2004, he served as Chief Financial Officer of Cholestech Corporation, a medical diagnostic products company.Mr. Burke received his bachelor's degree in Finance from the University of Texas at Austin and an MBA from the Wharton School of the University of Pennsylvania.Mr. Burke has served on numerous public and private company boards including serving as a board chairman and a lead independent director. He has served on the board of Tactile Systems Technology, Inc. (NASDAQ: TCMD) since 2015 and currently serves as Chairman of the Board and as a member of its nominating and governance committee. Since 2022, he has served on the board of directors of Ceribell Inc., (NASDAQ: CBLL), a medical technology company. Mr. Burke also currently chairs Ceribell's audit committee and serves on the nominating and governance committee. In 2024, he joined the board of Nalu Medical, Inc., a privately-held, medical technology company. He previously served on the board of Invuity, Inc. (acquired by Stryker Corp. in 2018), LDR Holding Corporation (acquired by Zimmer Biomet in 2016), and Medical Action Industries (acquired by Owens & Minor in 2014). - William W. Burke，自2022年6月起担任Ceribell，Inc.董事会成员。从2015年11月到2024年6月担任Austin Highlands Advisors, LLC（企业咨询服务提供商）的总裁。2009年11月至2013年8月被Abbott Laboratories收购，他担任IDEV Technologies, Inc.（外围血管设备公司）的执行副总裁兼首席财务官。从2004年8月到2007年12月，他担任ReAble Therapeutics, Inc.的执行副总裁兼首席财务官，ReAble Therapeutics是一家多元化的骨科设备公司，于2006年出售给Blackstone Group进行私人交易，随后于2007年11月与DJO Incorporated合并。他一直在ReAble Therapeutics工作到2008年6月。从2001年到2004年，他担任Cholestech Corporation（医疗诊断产品公司）的首席财务官。他曾担任许多上市和私人公司的董事会成员，包括担任董事会主席和首席独立董事。他目前担任Nalu Medical（为慢性神经性疼痛患者提供微创解决方案的私人制造商）、Adtalem Global Education（医疗保健教育公司）和Tactile Systems Technology（为慢性疾病患者提供治疗的医疗技术公司）的董事会成员。他曾担任EQ Health Acquisition Corp.、Invuity, Inc.（2018年被Stryker Corporation收购）、LDR Holding Corporation（2016年被Zimmer Biomet收购）和Medical Action Industries Inc.（2014年被Owens & Minor收购）的董事会成员。他持有The University of Texas at Austin的金融学士学位和The Wharton School of The University of Pennsylvania的工商管理硕士学位。
- William W. Burke,has been a director of Adtalem since January 2017. He served as Adtalem Global Education Inc. Lead Independent Director from July 2019 through November 2022. From November 2015 to June 2024, Mr. Burke served as President of Austin Highlands Advisors, LLC, a provider of corporate advisory services. He served as Executive Vice President & Chief Financial Officer of IDEV Technologies, a peripheral vascular devices company, from November 2009 until the company was acquired by Abbott Laboratories in August 2013. From August 2004 to December 2007, he served as Executive Vice President & Chief Financial Officer of ReAble Therapeutics, a diversified orthopedic device company which was sold to The Blackstone Group in a going private transaction in 2006 and subsequently merged with DJO Incorporated in November 2007. Mr. Burke remained with ReAble Therapeutics until June 2008. From 2001 to 2004, he served as Chief Financial Officer of Cholestech Corporation, a medical diagnostic products company.Mr. Burke received his bachelor's degree in Finance from the University of Texas at Austin and an MBA from the Wharton School of the University of Pennsylvania.Mr. Burke has served on numerous public and private company boards including serving as a board chairman and a lead independent director. He has served on the board of Tactile Systems Technology, Inc. (NASDAQ: TCMD) since 2015 and currently serves as Chairman of the Board and as a member of its nominating and governance committee. Since 2022, he has served on the board of directors of Ceribell Inc., (NASDAQ: CBLL), a medical technology company. Mr. Burke also currently chairs Ceribell's audit committee and serves on the nominating and governance committee. In 2024, he joined the board of Nalu Medical, Inc., a privately-held, medical technology company. He previously served on the board of Invuity, Inc. (acquired by Stryker Corp. in 2018), LDR Holding Corporation (acquired by Zimmer Biomet in 2016), and Medical Action Industries (acquired by Owens & Minor in 2014).
- Christophe Lavigne
-
Christophe Lavigne ，是本公司的联合创始人之一，自2006年以来一直担任董事长、总裁兼首席执行官。另外，他自2002年以来一直在本公司的法国（French）子公司- LDR Medical S.A.S。“Medical”担任董事长兼总裁，以及自该公司前身2000年成立以来任总裁。Lavigne先生拥有着在脊柱器械公司担任职责范围不断扩大的职位的超过20年的经验，最后在一家私有的医疗设备生产商-JBS担任担任销售和营销总监，以及在B. Braun Melsungen AG 的一个分公司、医疗设备生产商- Neuro-Spine Director for Aesculap, Inc.担任销售和营销总监。他于2006年荣获了Ernst & Young的年度企业家French奖，以及获得了2011年度 Ernst & Young的德州（Texas）中部地区企业家French奖。他拥有法国（France）IUT Dijon的机械工程学位，以及ESARC Paris商学院的工商学位，以及European商学院Zurich联合会的市场营销（DEESMA）硕士学位。
Christophe Lavigne is one of our co-founders and has served as Chairman of the Board of Directors, President and Chief Executive Officer since 2006. Biographical information for Mr. Lavigne is set forth under. - Christophe Lavigne ，是本公司的联合创始人之一，自2006年以来一直担任董事长、总裁兼首席执行官。另外，他自2002年以来一直在本公司的法国（French）子公司- LDR Medical S.A.S。“Medical”担任董事长兼总裁，以及自该公司前身2000年成立以来任总裁。Lavigne先生拥有着在脊柱器械公司担任职责范围不断扩大的职位的超过20年的经验，最后在一家私有的医疗设备生产商-JBS担任担任销售和营销总监，以及在B. Braun Melsungen AG 的一个分公司、医疗设备生产商- Neuro-Spine Director for Aesculap, Inc.担任销售和营销总监。他于2006年荣获了Ernst & Young的年度企业家French奖，以及获得了2011年度 Ernst & Young的德州（Texas）中部地区企业家French奖。他拥有法国（France）IUT Dijon的机械工程学位，以及ESARC Paris商学院的工商学位，以及European商学院Zurich联合会的市场营销（DEESMA）硕士学位。
- Christophe Lavigne is one of our co-founders and has served as Chairman of the Board of Directors, President and Chief Executive Officer since 2006. Biographical information for Mr. Lavigne is set forth under.
- Joseph Aragona
-
Joseph Aragona，是一个风险投资公司- Austin Ventures的创始人之一，自1982年以来一直任一般合伙人。他曾投资了一系列的行业，包括医疗设备、软件、服务、工业产品和特殊情况。他目前在一些私有企业的董事会任职。拥有Harvard大学经济学学士学位，以及Harvard商学院的工商管理学硕士学位。
Joseph Aragona is one of the founders of Austin Ventures, a venture capital firm, and has served as general partner since 1982. He has invested in a broad range of industries, including medical device, software, services, industrial products and special situations. Mr. Aragona serves on the boards of directors of a number of private companies. Mr. Aragona holds an A.B. in Economics from Harvard University and an M.B.A. from the Harvard Business School. - Joseph Aragona，是一个风险投资公司- Austin Ventures的创始人之一，自1982年以来一直任一般合伙人。他曾投资了一系列的行业，包括医疗设备、软件、服务、工业产品和特殊情况。他目前在一些私有企业的董事会任职。拥有Harvard大学经济学学士学位，以及Harvard商学院的工商管理学硕士学位。
- Joseph Aragona is one of the founders of Austin Ventures, a venture capital firm, and has served as general partner since 1982. He has invested in a broad range of industries, including medical device, software, services, industrial products and special situations. Mr. Aragona serves on the boards of directors of a number of private companies. Mr. Aragona holds an A.B. in Economics from Harvard University and an M.B.A. from the Harvard Business School.
- Kevin M. Lalande
-
Kevin M. Lalande，是一个风险投资公司-Sant Ventures的创始人之一及总经理。在2006年创立Sant Ventures之前，他曾在Austin Ventures工作了7年。在加入Austin Ventures之前，他曾是McKinsey & Company的一位管理顾问。此前，他联合创立和售出了3个公司： NetProfit于1996年被卖给了一个私有广告公司；Serus于1998年被卖给了Netopia；以及TimeMarker于2001年卖给了PrimeHoldings。他拥有Brigham Young大学的电气和计算机工程学士学位，以及以优异的成绩从Harvard商学院获得了工商管理学硕士学位。
Kevin M. Lalande,has been a director of the Company since August 2017, effective as of the Merger. Mr. Lalande served on the board of directors of Private Molecular since 2009. Since March 2007, Mr. Lalande has served as the Managing Member of SHV Management Services, LLC, a multi-strategy investment partnership with over $900 million in capital under management. Since March 2016, Mr. Lalande has served as the Founder and Chief Investment Officer of Sante Capital Management, LP. Mr. Lalande currently serves as a director for a number of privately-held companies as well as Lumos Pharma, Inc., a publicly-traded biotechnology company, and previously served as a director for LDR Holding Corporation, now Zimmer Biomet, a publicly-traded medical device company. Mr. Lalande holds a B.S. in Electrical and Computer Engineering from Brigham Young University, an M.B.A. with Highest Distinction from the Harvard Business School, and a graduate certificate in Artificial Intelligence from Stanford University. - Kevin M. Lalande，是一个风险投资公司-Sant Ventures的创始人之一及总经理。在2006年创立Sant Ventures之前，他曾在Austin Ventures工作了7年。在加入Austin Ventures之前，他曾是McKinsey & Company的一位管理顾问。此前，他联合创立和售出了3个公司： NetProfit于1996年被卖给了一个私有广告公司；Serus于1998年被卖给了Netopia；以及TimeMarker于2001年卖给了PrimeHoldings。他拥有Brigham Young大学的电气和计算机工程学士学位，以及以优异的成绩从Harvard商学院获得了工商管理学硕士学位。
- Kevin M. Lalande,has been a director of the Company since August 2017, effective as of the Merger. Mr. Lalande served on the board of directors of Private Molecular since 2009. Since March 2007, Mr. Lalande has served as the Managing Member of SHV Management Services, LLC, a multi-strategy investment partnership with over $900 million in capital under management. Since March 2016, Mr. Lalande has served as the Founder and Chief Investment Officer of Sante Capital Management, LP. Mr. Lalande currently serves as a director for a number of privately-held companies as well as Lumos Pharma, Inc., a publicly-traded biotechnology company, and previously served as a director for LDR Holding Corporation, now Zimmer Biomet, a publicly-traded medical device company. Mr. Lalande holds a B.S. in Electrical and Computer Engineering from Brigham Young University, an M.B.A. with Highest Distinction from the Harvard Business School, and a graduate certificate in Artificial Intelligence from Stanford University.
- Stefan Widensohler
-
Stefan Widensohler，自1992年以来一直在德国（Germany）Hamburg一家私有企业- KRAUTH medical KG担任总裁、首席执行官、负责人及所有者。一直到2002年， KRAUTH medical KG曾是医疗设备分销商和服务公司。KRAUTH medical KG后来将其医疗设备分销和服务业务销售出去，目前从事对初创医疗企业的投资。1996年，他在意大利联合创立了一家从事介入式心脏病和外周血管产品的医疗设备公司-Invatec SpA（该公司于2010年被Medtronic股份有限公司收购）。在收购之后，他加入了Medtronic公司并担任收购业务的全球销售副总裁，一直到2012年协助Invatec并入Medtronic。自2013年7月以来，他一直在一个公开上市的医疗设备公司- St. Jude Medical担任董事。自2011年1月以来，他一直在一个私有的医疗设备公司- MyoPowers Medical Technologies SA担任董事。他目前是一个私募股权基金- TowerBrook Capital Partners L.P。的顾问委员会成员。他还在分别在BVMed、德国卫生制造行业协会担任副理事长。他是德国（Germany）Harzburg的Private学院的一位经济学毕业生。
Stefan Widensohler is the President, Chief Executive Officer, Principal and Proprietor of KRAUTH medical KG, a privately held company in Hamburg, Germany. Until 2012 KRAUTH medical KG was a medical device distribution and service company. KRAUTH medical KG sold its medical device distribution and service business and now focuses on investing in healthcare start-up companies. In 1996 Mr. Widensohler also co-founded Invatec SpA, an Italian medical device company that specialized in interventional cardiology and peripheral vascular products, which was acquired by Medtronic, Inc. in 2010. Mr. Widensohler joined Medtronic following the acquisition and served as Vice President, Global Sales for the acquired business until 2012 to assist with the integration of Invatec into Medtronic. Since July 2013 Mr. Widensohler has served as a director of St. Jude Medical, a publicly traded medical device company. From January 2011 until January 2015 Mr. Widensohler served as a director of MyoPowers Medical Technologies SA, a privately held medical device company. He serves as Member of the Advisory Board of TowerBrook Capital Partners L.P., a private equity fund. He also serves as deputy chairman of the Board of BVMed, the German Health Industry Manufacturers Association. Mr. Widensohler is an Economics graduate from the Private Academy of Bad Harzburg, Germany. - Stefan Widensohler，自1992年以来一直在德国（Germany）Hamburg一家私有企业- KRAUTH medical KG担任总裁、首席执行官、负责人及所有者。一直到2002年， KRAUTH medical KG曾是医疗设备分销商和服务公司。KRAUTH medical KG后来将其医疗设备分销和服务业务销售出去，目前从事对初创医疗企业的投资。1996年，他在意大利联合创立了一家从事介入式心脏病和外周血管产品的医疗设备公司-Invatec SpA（该公司于2010年被Medtronic股份有限公司收购）。在收购之后，他加入了Medtronic公司并担任收购业务的全球销售副总裁，一直到2012年协助Invatec并入Medtronic。自2013年7月以来，他一直在一个公开上市的医疗设备公司- St. Jude Medical担任董事。自2011年1月以来，他一直在一个私有的医疗设备公司- MyoPowers Medical Technologies SA担任董事。他目前是一个私募股权基金- TowerBrook Capital Partners L.P。的顾问委员会成员。他还在分别在BVMed、德国卫生制造行业协会担任副理事长。他是德国（Germany）Harzburg的Private学院的一位经济学毕业生。
- Stefan Widensohler is the President, Chief Executive Officer, Principal and Proprietor of KRAUTH medical KG, a privately held company in Hamburg, Germany. Until 2012 KRAUTH medical KG was a medical device distribution and service company. KRAUTH medical KG sold its medical device distribution and service business and now focuses on investing in healthcare start-up companies. In 1996 Mr. Widensohler also co-founded Invatec SpA, an Italian medical device company that specialized in interventional cardiology and peripheral vascular products, which was acquired by Medtronic, Inc. in 2010. Mr. Widensohler joined Medtronic following the acquisition and served as Vice President, Global Sales for the acquired business until 2012 to assist with the integration of Invatec into Medtronic. Since July 2013 Mr. Widensohler has served as a director of St. Jude Medical, a publicly traded medical device company. From January 2011 until January 2015 Mr. Widensohler served as a director of MyoPowers Medical Technologies SA, a privately held medical device company. He serves as Member of the Advisory Board of TowerBrook Capital Partners L.P., a private equity fund. He also serves as deputy chairman of the Board of BVMed, the German Health Industry Manufacturers Association. Mr. Widensohler is an Economics graduate from the Private Academy of Bad Harzburg, Germany.
高管简历
中英对照 | 中文 | 英文- Christophe Lavigne
Christophe Lavigne ，是本公司的联合创始人之一，自2006年以来一直担任董事长、总裁兼首席执行官。另外，他自2002年以来一直在本公司的法国（French）子公司- LDR Medical S.A.S。“Medical”担任董事长兼总裁，以及自该公司前身2000年成立以来任总裁。Lavigne先生拥有着在脊柱器械公司担任职责范围不断扩大的职位的超过20年的经验，最后在一家私有的医疗设备生产商-JBS担任担任销售和营销总监，以及在B. Braun Melsungen AG 的一个分公司、医疗设备生产商- Neuro-Spine Director for Aesculap, Inc.担任销售和营销总监。他于2006年荣获了Ernst & Young的年度企业家French奖，以及获得了2011年度 Ernst & Young的德州（Texas）中部地区企业家French奖。他拥有法国（France）IUT Dijon的机械工程学位，以及ESARC Paris商学院的工商学位，以及European商学院Zurich联合会的市场营销（DEESMA）硕士学位。
Christophe Lavigne is one of our co-founders and has served as Chairman of the Board of Directors, President and Chief Executive Officer since 2006. Biographical information for Mr. Lavigne is set forth under.- Christophe Lavigne ，是本公司的联合创始人之一，自2006年以来一直担任董事长、总裁兼首席执行官。另外，他自2002年以来一直在本公司的法国（French）子公司- LDR Medical S.A.S。“Medical”担任董事长兼总裁，以及自该公司前身2000年成立以来任总裁。Lavigne先生拥有着在脊柱器械公司担任职责范围不断扩大的职位的超过20年的经验，最后在一家私有的医疗设备生产商-JBS担任担任销售和营销总监，以及在B. Braun Melsungen AG 的一个分公司、医疗设备生产商- Neuro-Spine Director for Aesculap, Inc.担任销售和营销总监。他于2006年荣获了Ernst & Young的年度企业家French奖，以及获得了2011年度 Ernst & Young的德州（Texas）中部地区企业家French奖。他拥有法国（France）IUT Dijon的机械工程学位，以及ESARC Paris商学院的工商学位，以及European商学院Zurich联合会的市场营销（DEESMA）硕士学位。
- Christophe Lavigne is one of our co-founders and has served as Chairman of the Board of Directors, President and Chief Executive Officer since 2006. Biographical information for Mr. Lavigne is set forth under.
- Robert McNamara
Robert McNamara，自2012年以来一直任本公司的财务总监，自2013年1月以来一直任本公司的副执行总裁。2010年9月-2012年4月期间，他主要在医疗设备和生物技术行业担任财务顾问。2009年5月-2010年9月期间，他曾在一个私有清洁技术公司- Purfresh, Inc.担任财务总监。2004年12月-2008年9月期间，他曾在一个公开上市的医疗设备制造商- Accuray, Inc.担任高级副总裁及财务总监。另外，他曾在公开上市的医疗设备公司- Somnus Medical Technologies 和Target Therapeutics担任高级副总裁兼财务总监，曾是Northstar Neurosciences的一位董事会成员，加州（California）Menlo Park市的前市长。他拥有San Francisco大学的会计学学士学位，以及Pennsylvania大学Wharton学院的金融专业工商管理学硕士学位。
Robert McNamara,has served as a member of Xtant Medical Holdings, Inc. Board since February 2018. Mr. McNamara was initially elected to the Board in connection with Xtant Medical Holdings, Inc. restructuring in February 2018. He also serves as Audit Committee Chairman of Axonics, Inc. (AXNX) and as a board member of Alpha Teknova, Inc. (TKNO). From January 2013 to July 2016, Mr. McNamara served as Executive Vice President and from April 2012 to July 2016 as the Chief Financial Officer for LDR Holding Corporation, a publicly held medical device (spinal implants) company acquired by Zimmer Biomet Holdings, Inc. In addition, Mr. McNamara has previously served as the Senior Vice President and Chief Financial Officer for publicly traded medical device companies including Accuray Inc., a stereotactic radiation company focused on treating cancer Xtant Medical Holdings, Inc. ing AI robotics, Somnus Medical Technologies Inc., a RF energy company focused on treating upper airway breathing disorders, and Target Therapeutics, Inc., a minimally invasive catheter and device company treating vascular diseases of the brain. Mr. McNamara has been a member of the board of directors of Northstar Neurosciences Inc. and is the former Mayor of Menlo Park, California. Mr. McNamara began his career in public accounting and is a certified public accountant (current status inactive). Mr. McNamara holds a Bachelor of Science in Accounting from the University of San Francisco and a Master of Business Administration in Finance from The Wharton School at the University of Pennsylvania.- Robert McNamara，自2012年以来一直任本公司的财务总监，自2013年1月以来一直任本公司的副执行总裁。2010年9月-2012年4月期间，他主要在医疗设备和生物技术行业担任财务顾问。2009年5月-2010年9月期间，他曾在一个私有清洁技术公司- Purfresh, Inc.担任财务总监。2004年12月-2008年9月期间，他曾在一个公开上市的医疗设备制造商- Accuray, Inc.担任高级副总裁及财务总监。另外，他曾在公开上市的医疗设备公司- Somnus Medical Technologies 和Target Therapeutics担任高级副总裁兼财务总监，曾是Northstar Neurosciences的一位董事会成员，加州（California）Menlo Park市的前市长。他拥有San Francisco大学的会计学学士学位，以及Pennsylvania大学Wharton学院的金融专业工商管理学硕士学位。
- Robert McNamara,has served as a member of Xtant Medical Holdings, Inc. Board since February 2018. Mr. McNamara was initially elected to the Board in connection with Xtant Medical Holdings, Inc. restructuring in February 2018. He also serves as Audit Committee Chairman of Axonics, Inc. (AXNX) and as a board member of Alpha Teknova, Inc. (TKNO). From January 2013 to July 2016, Mr. McNamara served as Executive Vice President and from April 2012 to July 2016 as the Chief Financial Officer for LDR Holding Corporation, a publicly held medical device (spinal implants) company acquired by Zimmer Biomet Holdings, Inc. In addition, Mr. McNamara has previously served as the Senior Vice President and Chief Financial Officer for publicly traded medical device companies including Accuray Inc., a stereotactic radiation company focused on treating cancer Xtant Medical Holdings, Inc. ing AI robotics, Somnus Medical Technologies Inc., a RF energy company focused on treating upper airway breathing disorders, and Target Therapeutics, Inc., a minimally invasive catheter and device company treating vascular diseases of the brain. Mr. McNamara has been a member of the board of directors of Northstar Neurosciences Inc. and is the former Mayor of Menlo Park, California. Mr. McNamara began his career in public accounting and is a certified public accountant (current status inactive). Mr. McNamara holds a Bachelor of Science in Accounting from the University of San Francisco and a Master of Business Administration in Finance from The Wharton School at the University of Pennsylvania.
- Scott Way
Scott Way，自2011年1月以来一直任本公司法律总顾问和合规官，自2012年5月以来一直任本公司秘书，以及自2013年1月以来一直任本公司副执行总裁。2007年11月-2011年1月期间，他曾在一家医疗设备制造商- DJO Incorporated的分公司企业法律顾问，主要负责外科植入和持久医疗药品部的所有法律相关事宜。在2004年12月-2007年11月期间，他曾是一家于2006年被Blackstone Group（于2007年11月与DJO合并）收购并将进行私有化的上市医疗设备制造商- Encore Medical股份有限公司的企业法律顾问。他拥有Kenyon大学的政治学学士学位，以及Texas大学法学院的法学博士学位。
Scott Way has served as our Executive Vice President since January 2013 and as our General Counsel and Compliance Officer since January 2011 and as our Secretary since May 2012. From November 2007 to January 2011 Mr. Way served as Corporate Counsel for a division of DJO Incorporated, a medical device manufacturer, with primary responsibility for all legal matters related to its surgical implant and durable medical goods divisions. From December 2004 to November 2007 he was Corporate Counsel for Encore Medical, Inc., a public company and manufacturer of medical devices that was acquired by the Blackstone Group in a going private transaction in 2006 and later merged in November of 2007 with DJO. Mr. Way holds a B.A. in Political Science from Kenyon College and a J.D. from The University of Texas School of Law.- Scott Way，自2011年1月以来一直任本公司法律总顾问和合规官，自2012年5月以来一直任本公司秘书，以及自2013年1月以来一直任本公司副执行总裁。2007年11月-2011年1月期间，他曾在一家医疗设备制造商- DJO Incorporated的分公司企业法律顾问，主要负责外科植入和持久医疗药品部的所有法律相关事宜。在2004年12月-2007年11月期间，他曾是一家于2006年被Blackstone Group（于2007年11月与DJO合并）收购并将进行私有化的上市医疗设备制造商- Encore Medical股份有限公司的企业法律顾问。他拥有Kenyon大学的政治学学士学位，以及Texas大学法学院的法学博士学位。
- Scott Way has served as our Executive Vice President since January 2013 and as our General Counsel and Compliance Officer since January 2011 and as our Secretary since May 2012. From November 2007 to January 2011 Mr. Way served as Corporate Counsel for a division of DJO Incorporated, a medical device manufacturer, with primary responsibility for all legal matters related to its surgical implant and durable medical goods divisions. From December 2004 to November 2007 he was Corporate Counsel for Encore Medical, Inc., a public company and manufacturer of medical devices that was acquired by the Blackstone Group in a going private transaction in 2006 and later merged in November of 2007 with DJO. Mr. Way holds a B.A. in Political Science from Kenyon College and a J.D. from The University of Texas School of Law.
- Andre Potgieter
Andre Potgieter ，自2013年1月以来一直任本公司的美国（U.S。）销售部副执行总裁，在2007年10月-2013年1月期间任美国（U.S。）销售部副总裁。他拥有脊髓植入行业的20年的经验，包括一个Medtronic Spine LLC的分公司、微创脊柱外科方案的供应商--Kyphon Global股份有限公司的8年的销售、区域销售管理和销售职位主管、一个被Johnson & Johnson收购的、骨科和神经解决方案的供应商- Synthes Spine的7年的脊柱顾问。他拥有Tennessee大学的金融学学士学位。
Andre Potgieter has served as our Executive Vice President, U.S. Sales since January 2013 and as our Vice President, U.S. Sales from October 2007 to January 2013. He has spent 22 years in the spinal implant industry, including eight years in Sales, Regional Sales Management and Director of Sales positions with Kyphon Global, Inc., a provider of minimally invasive spinal surgery solutions and a division of Medtronic Spine LLC, and seven years as a Spine Consultant with Synthes Spine, a provider of orthopedic and neurological solutions acquired by Johnson & Johnson. Mr. Potgieter holds a B.A. in Finance from the University of Tennessee.- Andre Potgieter ，自2013年1月以来一直任本公司的美国（U.S。）销售部副执行总裁，在2007年10月-2013年1月期间任美国（U.S。）销售部副总裁。他拥有脊髓植入行业的20年的经验，包括一个Medtronic Spine LLC的分公司、微创脊柱外科方案的供应商--Kyphon Global股份有限公司的8年的销售、区域销售管理和销售职位主管、一个被Johnson & Johnson收购的、骨科和神经解决方案的供应商- Synthes Spine的7年的脊柱顾问。他拥有Tennessee大学的金融学学士学位。
- Andre Potgieter has served as our Executive Vice President, U.S. Sales since January 2013 and as our Vice President, U.S. Sales from October 2007 to January 2013. He has spent 22 years in the spinal implant industry, including eight years in Sales, Regional Sales Management and Director of Sales positions with Kyphon Global, Inc., a provider of minimally invasive spinal surgery solutions and a division of Medtronic Spine LLC, and seven years as a Spine Consultant with Synthes Spine, a provider of orthopedic and neurological solutions acquired by Johnson & Johnson. Mr. Potgieter holds a B.A. in Finance from the University of Tennessee.
- James Burrows
James Burrows，自2009年12月以来一直任本公司的首席运营官，自2013年1月以来一直本公司的副执行总裁。他是于2005年加入LDR的。2001-2004年期间，他曾是一个于2003年被Zimmer Orthopedics收购的、肌肉骨骼健康发难的供应商- Centerpulse Orthopedics的产品营销总监。曾在Intermedics Orthopedics、 Sulzer Medica 以及 Centerpulse工作过的他，拥有着骨科脊柱行业的超过20年的经验，曾担任各种领导职位，包括战略、营销、技术和物流职位。他拥有4个美国（U.S。）的医疗设备产品设计专利。他拥有Texas州立大学的工程科技学士学位，以及工商管理学硕士学位。
James Burrows has served as our Executive Vice President since January 2013 and as our Chief Operating Officer since December 2009. Mr. Burrows joined LDR in January 2005. From 2001 to 2004 Mr. Burrows was the Director of Product Marketing for Centerpulse Orthopedics, a provider of musculoskeletal health solutions that was acquired by Zimmer Orthopedics in May 2003. Mr. Burrows has over 22 years of experience in the orthopedic and spine industry, working for Intermedics Orthopedics, Sulzer Medica and Centerpulse and has served in various leadership roles including strategic, marketing, technical and logistical duties. He holds six U.S. patents on medical device product designs. Mr. Burrows holds a B.S. in Engineering Technology and an M.B.A. from Texas State University.- James Burrows，自2009年12月以来一直任本公司的首席运营官，自2013年1月以来一直本公司的副执行总裁。他是于2005年加入LDR的。2001-2004年期间，他曾是一个于2003年被Zimmer Orthopedics收购的、肌肉骨骼健康发难的供应商- Centerpulse Orthopedics的产品营销总监。曾在Intermedics Orthopedics、 Sulzer Medica 以及 Centerpulse工作过的他，拥有着骨科脊柱行业的超过20年的经验，曾担任各种领导职位，包括战略、营销、技术和物流职位。他拥有4个美国（U.S。）的医疗设备产品设计专利。他拥有Texas州立大学的工程科技学士学位，以及工商管理学硕士学位。
- James Burrows has served as our Executive Vice President since January 2013 and as our Chief Operating Officer since December 2009. Mr. Burrows joined LDR in January 2005. From 2001 to 2004 Mr. Burrows was the Director of Product Marketing for Centerpulse Orthopedics, a provider of musculoskeletal health solutions that was acquired by Zimmer Orthopedics in May 2003. Mr. Burrows has over 22 years of experience in the orthopedic and spine industry, working for Intermedics Orthopedics, Sulzer Medica and Centerpulse and has served in various leadership roles including strategic, marketing, technical and logistical duties. He holds six U.S. patents on medical device product designs. Mr. Burrows holds a B.S. in Engineering Technology and an M.B.A. from Texas State University.
- G. Joseph Ross
G. Joseph Ross，自2010年以来一直任本公司美国（U.S。）营销部的副总裁，自2013年1月以来一直在本公司任全球营销副执行总裁。1995-2007年期间，他曾在Johnson & Johnson的一个分公司- DePuy Spine担任若干职位，并不断升职，包括在销售部和营销部任职，最后是在新业务开发部担任全球副总裁。他拥有脊柱医疗器械行业的18年经验，拥有脊柱植入和设备设计的多个专利。他拥有Notre Dame大学的市场营销学士学位，以及Troy大学的管理学硕士学位。他还曾在美国海军（United States Navy）担任过5年的军官。
G. Joseph Ross has served as our Executive Vice President of Global Marketing since January 2013 and as our Vice President of U.S. Marketing since 2010. From 1995 to 2007 Mr. Ross served in a variety of roles of increasing responsibility for DePuy Spine, a division of Johnson & Johnson, including sales, marketing and lastly as Worldwide Vice President of New Business Development. Mr. Ross has 20 years of experience in the spine medical device industry and holds multiple patents for spine implant and instrument designs. Mr. Ross holds a BBA in Marketing from the University of Notre Dame and an MS in Management from Troy University. He also served five years as an officer in the United States Navy.- G. Joseph Ross，自2010年以来一直任本公司美国（U.S。）营销部的副总裁，自2013年1月以来一直在本公司任全球营销副执行总裁。1995-2007年期间，他曾在Johnson & Johnson的一个分公司- DePuy Spine担任若干职位，并不断升职，包括在销售部和营销部任职，最后是在新业务开发部担任全球副总裁。他拥有脊柱医疗器械行业的18年经验，拥有脊柱植入和设备设计的多个专利。他拥有Notre Dame大学的市场营销学士学位，以及Troy大学的管理学硕士学位。他还曾在美国海军（United States Navy）担任过5年的军官。
- G. Joseph Ross has served as our Executive Vice President of Global Marketing since January 2013 and as our Vice President of U.S. Marketing since 2010. From 1995 to 2007 Mr. Ross served in a variety of roles of increasing responsibility for DePuy Spine, a division of Johnson & Johnson, including sales, marketing and lastly as Worldwide Vice President of New Business Development. Mr. Ross has 20 years of experience in the spine medical device industry and holds multiple patents for spine implant and instrument designs. Mr. Ross holds a BBA in Marketing from the University of Notre Dame and an MS in Management from Troy University. He also served five years as an officer in the United States Navy.
- Patrick Richard
Patrick Richard ，是本公司的联合创始人之一，自2013年1月以来一直任副执行总裁。他自本公司2000年成立以来一直是欧洲销售部主管，以及LDR Medical董事。在过去的20年里，他曾在欧洲（Europe）多个脊柱器械公司工作，在欧洲（Europe）市场推介许多新方法和技术，包括微创脊柱前路手术、脊柱侧弯循序负荷和矫正应用，以及颈椎、腰椎间盘置换设备。他曾在一家私有的医疗设备制造商- JBS担任区域销售经理，在B. Braun Melsungen AG的分公司、一家法国（France）医疗设备的制造商- Aesculap股份有限公司的销售总监。
Patrick Richard is one of our co-founders, has served as Executive Vice President since January 2013 and as our head of European Sales and a director of LDR Medical since our founding in 2000. For the past 22 years, Mr. Richard has worked with spinal device companies in Europe to introduce numerous new procedures and technologies in the European market, including minimally invasive anterior spine surgery, sequential loading and correction for scoliosis applications and cervical and lumbar disc replacement devices. Mr. Richard served as regional sales manager for JBS, a privately held medical device manufacturer and as sales director of France for Aesculap, Inc., a medical device manufacturer and a division of B. Braun Melsungen AG.- Patrick Richard ，是本公司的联合创始人之一，自2013年1月以来一直任副执行总裁。他自本公司2000年成立以来一直是欧洲销售部主管，以及LDR Medical董事。在过去的20年里，他曾在欧洲（Europe）多个脊柱器械公司工作，在欧洲（Europe）市场推介许多新方法和技术，包括微创脊柱前路手术、脊柱侧弯循序负荷和矫正应用，以及颈椎、腰椎间盘置换设备。他曾在一家私有的医疗设备制造商- JBS担任区域销售经理，在B. Braun Melsungen AG的分公司、一家法国（France）医疗设备的制造商- Aesculap股份有限公司的销售总监。
- Patrick Richard is one of our co-founders, has served as Executive Vice President since January 2013 and as our head of European Sales and a director of LDR Medical since our founding in 2000. For the past 22 years, Mr. Richard has worked with spinal device companies in Europe to introduce numerous new procedures and technologies in the European market, including minimally invasive anterior spine surgery, sequential loading and correction for scoliosis applications and cervical and lumbar disc replacement devices. Mr. Richard served as regional sales manager for JBS, a privately held medical device manufacturer and as sales director of France for Aesculap, Inc., a medical device manufacturer and a division of B. Braun Melsungen AG.